new safety concerns with statins (simvastatin, atorvastatin, lovastatin, etc)

Patients will ask about new safety concerns with statins (simvastatin, atorvastatin, lovastatin, etc).

About 25% of adults over 45 are on a statin. Now new labeling will warn about a higher risk of diabetes and mental impairment.

Tell patients not to be overly alarmed...and NOT to stop their statin without talking to their pharmacist or prescriber first. The benefits from statins are likely greater than these risks.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote